534602-93-2

Upstream product

• 124-25-4 myristylaldehyde 
• 534602-92-1 [3-tert-butoxycarbonylamino-5-(tert-butyl-diphenyl-silanyloxy)-2-oxo-pentyl]-phosphonic acid dimethyl ester 
• 534602-90-9 C₃₁H₄₅NO₇Si 
• 534602-91-0 2-tert-butoxycarbonylamino-4-(tert-butyl-diphenyl-silanyloxy)-butyric acid methyl ester 
• 224192-24-9 methyl (2S)-2-{(tert-butoxy)-N-[(tert-butyl)oxycarbonyl]carbonylamino}-4-hydroxybutanoate 
• 58479-61-1 tert-butylchlorodiphenylsilane 

Downstream Products

• 534602-94-3 {1-[2-(tert-butyl-diphenyl-silanyloxy)-ethyl]-2-hydroxy-heptadec-3-enyl}-carbamic acid tert-butyl ester 
• 534602-95-4 {1-[2-(tert-butyl-diphenyl-silanyloxy)-ethyl]-2-oxo-heptadecyl}-carbamic acid tert-butyl ester 

Relevant academic research and scientific papers

Synthesis of non-natural C2-homo-ceramide and its apoptotic activity against HL-60 cells

Non-natural ceramide analogues, C2-homo-ceramide and C2-homo-dihydroceramide, were prepared from L-aspartic acid via L-homo-serine. The apoptotic activities of the synthesized ceramide analogues were examined in HL-60 human leukemia cells. C2-homo- and C2